{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T00:58:51Z","timestamp":1760057931801,"version":"build-2065373602"},"reference-count":33,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T00:00:00Z","timestamp":1741219200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background\/Objectives: Low bone mineral density (BMD) is common in hemophilia patients. Identifying high-risk patients for low BMD early is essential to prevent complications and reduce morbidity. The parathyroid hormone (PTH)\/calcium (Ca) ratio is a cost-effective marker for predicting BMD, highlighting the need for routine screening and early intervention in this population. Hemophilia is a hereditary bleeding disorder caused by deficiencies in clotting factors VIII (hemophilia A) and IX (hemophilia B). Patients with hemophilia are at risk of low bone mineral density (BMD). This study aimed to evaluate the prevalence of low BMD, associated risk factors, and raise awareness regarding its significance in hemophilia patients. Methods: We retrospectively assessed bone metabolism in 62 hemophilia patients followed at our center. BMD was evaluated using dual-energy X-ray absorptiometry (DEXA). Additionally, serum levels of 25-OH-D3, alkaline phosphatase, PTH, Ca, phosphor, and creatinine were measured. The PTH\/Ca, PTH\/25-OH-D3, and Ca\u00d725-OH-D3\/PTH ratios were calculated. Results: The median age of the 62 patients with hemophilia included in the study (hemophilia A: 87.1%, hemophilia B: 12.9%) was 37 years (range: 21\u201366), and all were male. Of these patients, 67.7% (n = 42) had severe, 21% (n = 13) had moderate, and 11.3% (n = 7) had mild hemophilia. A total of 85.5% of patients were on factor prophylaxis, and 75.4% had a target joint. In laboratory analysis, the median 25-OH-D3 level was 13.4 \u00b5g\/L and 75% patients had 25-OH-D3 deficiency. According to DEXA results, 62.9% had lower than normal BMD. When we divided the patients into normal and low BMD groups according to DEXA results, weight (p = 0.006), height (p = 0.024), factor levels (p = 0.004), PTH (p = 0.010), AST (p = 0.029), and PTH\/Ca (p = 0.011) levels were statistically significantly different between the groups. The severity of the disease and the rate of receiving prophylaxis were higher in the group with low BMD (p = 0.015, p = 0.006, respectively). In multivariate analysis, PTH\/Ca ratio and weight were found to be independent risk factors for BMD. A linear relationship was found between PTH\/Ca ratio and BMD. The optimal cut-off value for PTH\/Ca was 6.57, with a selectivity of 65% and specificity of 82%. When we divided the patients into groups according to the cut-off value of 6.57, we found that the probability of low BMD increased approximately 7-fold in the group with PTH\/Ca &gt; 6.57 (OR 7.045, 95% CI 1.485\u201333.42, p = 0.014). There was an inverse association between patient weight and low BMD (p = 0.043). Conclusions: Low BMD is a critical public health concern frequently observed in patients with hemophilia. The study highlights a high rate of low BMD and 25-OH-D3 deficiency in hemophilia patients, with the PTH\/Ca ratio shown to be useful in predicting BMD. The PTH\/Ca ratio is suggested as an accessible, cost-effective, and practical test for evaluating BMD in hemophilia patients.<\/jats:p>","DOI":"10.3390\/diagnostics15050638","type":"journal-article","created":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T06:02:13Z","timestamp":1741240933000},"page":"638","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Could PTH\/Ca Ratio Serve as a New Marker for Evaluating Bone Metabolism in Hemophilia Patients?"],"prefix":"10.3390","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5419-3221","authenticated-orcid":false,"given":"Tuba","family":"Ersal","sequence":"first","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Bursa Uludag University, Bursa 16059, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4991-9830","authenticated-orcid":false,"given":"Faz\u0131l \u00c7a\u011fr\u0131","family":"Hunutlu","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Bursa Uludag University, Bursa 16059, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vildan","family":"G\u00fcrsoy","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Bursa Uludag University, Bursa 16059, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ezel","family":"Elg\u00fcn","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Bursa Uludag University, Bursa 16059, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u015eeyma","family":"Yavuz","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Bursa Uludag University, Bursa 16059, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130pek","family":"Dal Akku\u015f","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, Bursa Uludag University, Bursa 16059, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130layda","family":"Ba\u015f","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, Bursa Uludag University, Bursa 16059, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vildan","family":"\u00d6zkocaman","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Bursa Uludag University, Bursa 16059, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9710-134X","authenticated-orcid":false,"given":"Fahir","family":"\u00d6zkalemka\u015f","sequence":"additional","affiliation":[{"name":"Division of Hematology, Department of Internal Medicine, Faculty of Medicine, Bursa Uludag University, Bursa 16059, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,3,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1365-2516.2012.02909.x","article-title":"Guidelines for the management of hemophilia","volume":"19","author":"Srivastava","year":"2013","journal-title":"Haemophilia"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/S0140-6736(11)61139-2","article-title":"Modern haemophilia care","volume":"379","author":"Berntorp","year":"2012","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1055\/s-0037-1615621","article-title":"Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis","volume":"85","author":"White","year":"2001","journal-title":"Thromb. Haemost."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/hae.14046","article-title":"WFH Guidelines for the Management of Hemophilia, 3rd edition","volume":"26","author":"Srivastava","year":"2020","journal-title":"Haemophilia"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/MBC.0000000000000330","article-title":"Haemophilia A and B as a cause for secondary osteoporosis and increased fracture risk","volume":"26","author":"Anagnostis","year":"2015","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11657-022-01203-9","article-title":"Pathogenesis and treatment of osteoporosis in patients with hemophilia","volume":"18","author":"Lin","year":"2023","journal-title":"Arch. Osteoporos."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1111\/jth.13441","article-title":"Coagulation and non-coagulation effects of thrombin","volume":"14","author":"Posma","year":"2016","journal-title":"J. Thromb. Haemost."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/hae.13814","article-title":"Risk of osteoporotic fractures as a consequence of haemophilia: A nationwide population-based cohort study","volume":"25","author":"Tuan","year":"2019","journal-title":"Haemophilia"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1210\/jc.2011-3045","article-title":"Osteoporosis in men: An Endocrine Society clinical practice guideline","volume":"97","author":"Watts","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.bone.2008.08.106","article-title":"International Society for Clinical Densitometry 2007 Adult and Pediatric Official Positions","volume":"43","author":"Lewiecki","year":"2008","journal-title":"Bone"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"102624","DOI":"10.1016\/j.rpth.2024.102624","article-title":"The influence of severity of hemophilia on bone mineral density and fracture risk","volume":"8","author":"Ransmann","year":"2024","journal-title":"Res. Pract. Thromb. Haemost."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1111\/hae.13836","article-title":"Decreased bone mineral density and associated factors in severe haemophilia A patients: A case-control study","volume":"25","author":"Ekinci","year":"2019","journal-title":"Haemophilia"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Wu, D., and Shen, S. (2023). Osteoporosis and associated risk factors in patients with severe hemophilia A: A case-control study from China. BMC Musculoskelet. Disord., 24.","DOI":"10.1186\/s12891-023-06795-y"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2516.2008.01963.x","article-title":"Prevalence and risk factors associated with decreased bone mineral density in patients with haemophilia","volume":"15","author":"Gerstner","year":"2009","journal-title":"Haemophilia"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1365-2141.2012.09101.x","article-title":"Decreased bone density and bone strength in a mouse model of severe factor VIII deficiency","volume":"158","author":"Liel","year":"2012","journal-title":"Br. J. Haematol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1111\/hae.12195","article-title":"The bone disease associated with factor VIII deficiency in mice is secondary to increased bone resorption","volume":"19","author":"Recht","year":"2013","journal-title":"Haemophilia"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/bjh.13312","article-title":"Increased fracture rates in people with haemophilia: A 10-year single institution retrospective analysis","volume":"170","author":"Gay","year":"2015","journal-title":"Br. J. Haematol."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Gebetsberger, J., Schirmer, M., Wurzer, W.J., and Streif, W. (2022). Low Bone Mineral Density in Hemophiliacs. Front. Med., 9.","DOI":"10.3389\/fmed.2022.794456"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1542\/peds.114.2.e177","article-title":"Reduced bone density among children with severe hemophilia","volume":"114","author":"Barnes","year":"2004","journal-title":"Pediatrics"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1055\/s-0040-1718890","article-title":"Mechanisms of Bone Remodeling Disorder in Hemophilia","volume":"47","author":"Wang","year":"2021","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/hae.13384","article-title":"The role of sclerostin\/dickkopf-1 and receptor activator of nuclear factor kB ligand\/osteoprotegerin signalling pathways in the development of osteoporosis in patients with haemophilia A and B: A cross-sectional study","volume":"24","author":"Anagnostis","year":"2018","journal-title":"Haemophilia"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00223-020-00803-2","article-title":"Role of the RANK\/RANKL\/OPG and Wnt\/\u03b2-Catenin Systems in CKD Bone and Cardiovascular Disorders","volume":"108","author":"Dusso","year":"2021","journal-title":"Calcif. Tissue Int."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s00774-020-01175-1","article-title":"Discovery of the RANKL\/RANK\/OPG system","volume":"39","author":"Yasuda","year":"2021","journal-title":"J. Bone Miner. Metab."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"31704","DOI":"10.1074\/jbc.M109.030312","article-title":"Factor VIII-von Willebrand factor complex inhibits osteoclastogenesis and controls cell survival","volume":"284","author":"Duplomb","year":"2009","journal-title":"J. Biol. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"e97291","DOI":"10.5812\/compreped.97291","article-title":"Prevalence of Low Bone Mass in Patients with Hemophilia and Its Related Ractors in Southern Iran","volume":"11","author":"Bordbar","year":"2020","journal-title":"J. Compr. Pediatr."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.beem.2018.09.014","article-title":"Vitamin D insufficiency: Definition, diagnosis and management","volume":"32","author":"Bouillon","year":"2018","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1076029619861689","DOI":"10.1177\/1076029619861689","article-title":"Osteoporosis in Patients with Hemophilia: Single-Center Results from a Middle-Income Country","volume":"25","author":"Sahin","year":"2019","journal-title":"Clin. Appl. Thromb. Hemost."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.eprac.2024.04.013","article-title":"Relationship Between Serum 25-Hydroxyvitamin D and Bone Mineral Density, Fracture Risk, and Bone Metabolism in Adults with Osteoporosis\/Fractures","volume":"30","author":"Chen","year":"2024","journal-title":"Endocr. Pract."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1007\/s00198-004-1640-3","article-title":"Body mass index as a predictor of fracture risk: A meta-analysis","volume":"16","author":"Kanis","year":"2005","journal-title":"Osteoporos. Int."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s005350050076","article-title":"Longitudinal changes of bone mineral content with age in patients with cirrhosis of the liver","volume":"33","author":"Masaki","year":"1998","journal-title":"J. Gastroenterol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00277-009-0759-x","article-title":"Increased bone resorption is implicated in the pathogenesis of bone loss in hemophiliacs: Correlations with hemophilic arthropathy and HIV infection","volume":"89","author":"Katsarou","year":"2010","journal-title":"Ann. Hematol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1111\/j.1365-2516.2012.02899.x","article-title":"Hypovitaminosis D and osteopenia\/osteoporosis in a haemophilia population: A study in HCV\/HIV or HCV infected patients","volume":"19","author":"Linari","year":"2013","journal-title":"Haemophilia"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1111\/jth.15444","article-title":"Hemophilic arthropathy: Current knowledge and future perspectives","volume":"19","author":"Gualtierotti","year":"2021","journal-title":"J. Thromb. Haemost."}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/5\/638\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:48:05Z","timestamp":1760028485000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/15\/5\/638"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,6]]},"references-count":33,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,3]]}},"alternative-id":["diagnostics15050638"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics15050638","relation":{},"ISSN":["2075-4418"],"issn-type":[{"type":"electronic","value":"2075-4418"}],"subject":[],"published":{"date-parts":[[2025,3,6]]}}}